baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UC TUR.OP.END. BULL VX1/ DE000HC41QE8 /

09/08/2024 21:40:23	Chg.+0.210	Bid21:59:50	Ask21:59:50	Underlying	Strike price	Expiration date	Option type
17.710EUR	+1.20%	17.730 Bid Size: 6,000	17.760 Ask Size: 6,000	Vertex Pharmaceutica...	275.2945 USD	31/12/2078	Call

Newsfile Corp 17/07 Analysts Hunt for Undervalued Biotech Stocks

Newsfile Corp 11/07 Biopharma Stocks Transformative Innovation for the Future of Health

GlobeNewswire 28/06 Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Di...

GlobeNewswire 10/06 Centessa Pharmaceuticals Strengthens Executive Leadership with Appointment of John Crowley CPA, as C...

GlobeNewswire 29/05 CRISPR Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire 23/05 CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments

GlobeNewswire 15/05 Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 09/05 CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference

GlobeNewswire 08/05 CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

GlobeNewswire 08/05 CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo ...

GlobeNewswire 08/05 Editas Medicine Announces First Quarter 2024 Results and Business Updates

GlobeNewswire 07/05 Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 30/04 American Kidney Fund Encourages People to Be APOL1 Aware with First Annual APOL1-Mediated Kidney Dis...

GlobeNewswire 27/04 SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLC Investigates MODN, AIRC, INRD, ALPN

GlobeNewswire 25/04 American Kidney Fund Launches National Kidney Health Equity Media Campaign

GlobeNewswire 22/04 TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - ALPN, LABP, SWAV, FUS...

GlobeNewswire 22/04 CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASG...

GlobeNewswire 22/04 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INRD, AIRC, ELYM, ALPN

GlobeNewswire 22/04 Kuehn Law Encourages INRD, AIRC, ELYM, and ALPN Investors to Contact Law Firm

GlobeNewswire 20/04 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ADTH, MODN, ALPN

GlobeNewswire 16/04 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MGRC, ALPN, NXPL

GlobeNewswire 13/04 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MODN, ALPN, ELYM, JBT

GlobeNewswire 09/04 American Kidney Fund and Alonzo Mourning Call for More Awareness and Understanding of APOL1-Mediated...

GlobeNewswire 03/04 CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference

GlobeNewswire 01/04 CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates

UC TUR.OP.END. BULL VX1/ DE000HC41QE8 /

If you wish to receive reply to your feedback, please provide your email address.